Oxford Cannabinoid Technologies Stock Cash Flow From Operations
| OCTHF Stock | USD 0 0.00 0.00% |
Oxford Cannabinoid Technologies fundamentals help investors to digest information that contributes to Oxford Cannabinoid's financial success or failures. It also enables traders to predict the movement of Oxford Pink Sheet. The fundamental analysis module provides a way to measure Oxford Cannabinoid's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Oxford Cannabinoid pink sheet.
Oxford |
Oxford Cannabinoid Technologies Company Cash Flow From Operations Analysis
Oxford Cannabinoid's Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investors or analysts to check on the quality of a company's earnings.
Operating Cash Flow shows the difference between reported income and actual cash flows of the company. If a firm does not have enough cash or cash equivalents to cover its current liabilities, then both investors and management should be concerned about the company having enough liquid resources to meet current and long term debt obligations.
| Competition |
In accordance with the recently published financial statements, Oxford Cannabinoid Technologies has 0.0 in Cash Flow From Operations. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Biotechnology industry. The cash flow from operations for all United States stocks is 100.0% higher than that of the company.
Oxford Cash Flow From Operations Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Oxford Cannabinoid's direct or indirect competition against its Cash Flow From Operations to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Oxford Cannabinoid could also be used in its relative valuation, which is a method of valuing Oxford Cannabinoid by comparing valuation metrics of similar companies.Oxford Cannabinoid is currently under evaluation in cash flow from operations category among its peers.
Oxford Fundamentals
| Current Valuation | (3.87 M) | |||
| Shares Outstanding | 960.42 M | |||
| Shares Owned By Insiders | 44.08 % | |||
| Shares Owned By Institutions | 2.72 % | |||
| Price To Book | 0.41 X | |||
| Gross Profit | (3.15 M) | |||
| EBITDA | (5.63 M) | |||
| Book Value Per Share | 0.01 X | |||
| Market Capitalization | 11.9 M |
About Oxford Cannabinoid Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Oxford Cannabinoid Technologies's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Oxford Cannabinoid using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Oxford Cannabinoid Technologies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Oxford Pink Sheet
Oxford Cannabinoid financial ratios help investors to determine whether Oxford Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Oxford with respect to the benefits of owning Oxford Cannabinoid security.